Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Traboulsee

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
AJNR. American Journal of Neuroradiology|August 25, 2018
Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast AgentsH Kang, M Hii, M Le, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2014
Birth outcomes of pregnancies fathered by men with multiple sclerosisE Lu, F Zhu, Y Zhao, et al.
Neurology|July 10, 2002
Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MSA Traboulsee, J Dehmeshki, P A Brex, et al.
Neurology|June 10, 2010
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MSA T Reder, G C Ebers, A Traboulsee, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2010
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trialG C Ebers, A Traboulsee, D Li, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 11, 2019
Cannabis-based product use in a multiple sclerosis cohortA J Schabas, V Vukojevic, C Taylor, et al.
Neurology|September 27, 2006
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MSL Kappos, A Traboulsee, C Constantinescu, et al.
Neurology|October 7, 2011
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MSM S Freedman, A Bar-Or, J Oger, et al.
Neuroimage. Clinical|September 8, 2019
FLAIR<sup>2</sup> improves LesionTOADS automatic segmentation of multiple sclerosis lesions in non-homogenized, multi-center, 2D clinical magnetic resonance imagesM Le, L Y W Tang, E Hernández-Torres, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2003
Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalitiesA Traboulsee, J Dehmeshki, Kevin R Peters, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
AJNR. American Journal of Neuroradiology|August 25, 2018
Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast AgentsH Kang, M Hii, M Le, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2014
Birth outcomes of pregnancies fathered by men with multiple sclerosisE Lu, F Zhu, Y Zhao, et al.
Neurology|July 10, 2002
Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MSA Traboulsee, J Dehmeshki, P A Brex, et al.
Neurology|June 10, 2010
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MSA T Reder, G C Ebers, A Traboulsee, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2010
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trialG C Ebers, A Traboulsee, D Li, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 11, 2019
Cannabis-based product use in a multiple sclerosis cohortA J Schabas, V Vukojevic, C Taylor, et al.
Neurology|September 27, 2006
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MSL Kappos, A Traboulsee, C Constantinescu, et al.
Neurology|October 7, 2011
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MSM S Freedman, A Bar-Or, J Oger, et al.
Neuroimage. Clinical|September 8, 2019
FLAIR<sup>2</sup> improves LesionTOADS automatic segmentation of multiple sclerosis lesions in non-homogenized, multi-center, 2D clinical magnetic resonance imagesM Le, L Y W Tang, E Hernández-Torres, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2003
Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalitiesA Traboulsee, J Dehmeshki, Kevin R Peters, et al.
Pageof 3